https://www.selleckchem.com/pr....oducts/Fedratinib-SA
Since the outbreak of COVID-19 in China, it has rapidly spread across many other countries. We evaluated antioxidant defense systems and inflammatory status related to the SARS-CoV2 infection in a population from southwestern Iran. Comorbidities and clinical symptoms of 104 subjects (comprising negative and positive-PCR COVID-19 outpatients) were assessed. Serum concentrations of glutathione reductase (GR) and interleukin-10 (IL-1 were measured using ELISA. In the positive-PCR group, follow-ups on clinical sympto
Like
Comment
Share
